Activity Overview
Allergic conjunctivitis is a common source of ocular discomfort in the United States, but it is frequently underdiagnosed and undertreated. In this 4-part Burst™ series, an expert panel discusses the etiology of seasonal and perennial allergic conjunctivitis and examines opportunities to individualize therapy, with a particular focus on over the counter (OTC) options.
Target Audience
The
target audience for this program is ophthalmologists and optometrists who treat
ocular allergy.
Learning Objectives
Upon successful completion of this activity, you should be better
prepared to:
- Select therapeutic regimens for the treatment of allergic conjunctivitis

Walter Whitley, OD, MBA, FAAO
Director of Professional Relations and Education
Regional Medical Director—Mid-Atlantic
EyeCare Partners, LLC
Norfolk, VA
Consultant: Alcon, Allergan, Bausch + Lomb, Bruder, I-MED Pharma USA, Kala Pharmaceuticals, Novartis, Oyster Point Pharma, Regener-Eyes, Santen Pharmaceutical, ScienceBased Health, Sun Pharma, Tarsus Pharmaceuticals, Théa Pharma; Speakers’ Bureau: Alcon, Allergan, Bausch + Lomb, Kala Pharmaceuticals, Novartis, Oyster Point Pharma, Santen Pharmaceutical, ScienceBased Health, Sun Pharma

Cecelia Koetting, OD, FAAO, DipABO
Clinical Instructor
Department of Ophthalmology
University of Colorado School of Medicine
Denver, CO
Disclosure: Grant/Research Support: Johnson & Johnson, Ocular Therapeutix, Tarsus; Consultant: Aldeyra, Allergan, Avellino, Azura, B&L Twenty/Twenty, Blinkjoy, Bruder, Claris Bio, Dompé, Kala, Myze, Orasis, Sight Sciences, Tarsus, Théa, Verséa, Visus; Speaker’s Bureau: Alcon, Eyevance/Santen, Glaukos, Harrow, Oyster Point/Viatris, RVL
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
This accredited activity has been developed in accordance with applicable accreditation standards to ensure balance, independence, objectivity, and scientific rigor. Faculty were instructed to use generic names where possible and to base recommendations on the best available evidence.
In the context of clinical discussion, proprietary product names may be mentioned. Such references are made for educational purposes only and do not constitute endorsement of any commercial product or service.
Learners are encouraged to independently evaluate the information presented and apply their own clinical judgment when considering patient care decisions.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here

